MSME (Udyam registered) Ministry of MSME
- Udyam number
- UDYAM-CH-01-0006789
Oasis Pharma and Phytomolecules Private Limited
Oasis Pharma and Phytomolecules Private Limited - pharma in Chandigarh, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹10.36 Cr
▲ 48% YoY
Net profit · FY 2025
₹9.05 Lakh
Net margin 0.9%
EBITDA · FY 2025
₹76.72 Lakh
EBITDA margin 7.4%
Authorised capital
₹8 Cr
Registered with MCA
Paid-up capital
₹8 Cr
Issued & subscribed
Open charges
₹10.3 Cr
Satisfied ₹8.97 Cr
Company age
19 yrs
Est. 2007
Employees · EPFO
11
Provident fund records
About Oasis Pharma and Phytomolecules Private Limited
Data last updated:
Oasis Pharma and Phytomolecules Private Limited is a private limited company based in Chandigarh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 08 May 2007 and has been in existence for over 19 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24100CH2007PTC045485. Its GSTIN is 02AAACO9325R1Z3 (Himachal Pradesh). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹8 Cr and a paid-up capital of ₹8 Cr. It is led by directors Sanjay Dhir (Managing Director) and Sanjeev Kumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot 194 – 195. 3rd Floor, Industrial Area Phase – II, Chandigarh, India – 160002.
As per the financials filed for FY 2025, the company reported a revenue of ₹10.36 Cr, a growth of 48% compared to the previous year. For the same year it recorded a net profit of ₹9.05 Lakh (net margin 0.9%) and EBITDA of ₹76.72 Lakh (EBITDA margin 7.4%). Revenue has grown at a compounded annual rate (CAGR) of 440% over five years.
The company has about 11 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹10.3 Cr and satisfied charges of ₹8.97 Cr on record. Court records list 12 cases involving the company, including 3 filed by the company and 8 filed against it; 2 cases are pending. The company has 12 deals on record (6 funding rounds, 4 secondary share transfers, 2 rights issues), with disclosed funding of ₹5.42 Cr; the latest was in April 2019. Its 10 peer companies in the Pharma industry (Formulations) are compared by revenue, 5 larger and 5 smaller; the largest is Gujarat Liqui Pharmacaps Private Limited with revenue of ₹10.41 Cr.
Oasis Pharma and Phytomolecules Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-CH-01-0006789). The current compliance status is marked as compliant by the Registrar of Companies.
Company Details of Oasis Pharma and Phytomolecules Private Limited
CIN U24100CH2007PTC045485
Registration Number 045485
Incorporation Date 08 May 2007
ROC Chandigarh
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification MSME
Udyam Registration UDYAM-CH-01-0006789
CIN History of Oasis Pharma and Phytomolecules Private Limited
Oasis Pharma and Phytomolecules has one previous CIN (Corporate Identification Number): U24100DL2007PTC163076. The current CIN is U24100CH2007PTC045485, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24100CH2007PTC045485 | Current |
| U24100DL2007PTC163076 | Previous |
Recognitions & Rankings of Oasis Pharma and Phytomolecules
Contact Details
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressPlot 194 – 195. 3rd Floor, Industrial Area Phase – II, Chandigarh, India – 160002
- IndustryPharma, Drug Formulation & Development
Comprehensive company report
Oasis Pharma and Phytomolecules Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business Activity of Oasis Pharma and Phytomolecules Private Limited
The main business activity of Oasis Pharma and Phytomolecules is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Oasis Pharma and Phytomolecules Private Limited FY 2025 filings available
Oasis Pharma and Phytomolecules Private Limited reported revenue of ₹10.36 Cr (up 48% YoY) for FY 2025.
Revenue · FY 2025
₹10.36 Cr ▲ 48%
Net profit · FY 2025
₹9.05 Lakh margin 0.9%
EBITDA · FY 2025
₹76.72 Lakh margin 7.4%
Compounded Annual Growth Rate (CAGR) of Oasis Pharma and Phytomolecules Private Limited
Revenue CAGR growth
1 year
▲ 48%
5 years · compounded
▲ 440%
EBITDA CAGR growth
1 year
▼ 4%
3 years · compounded
▲ 128%
5 years · compounded
▲ 63%
Revenue has grown at a compounded annual rate (CAGR) of 440% over five years, including 48% growth in the latest year. EBITDA fell 4% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Oasis Pharma and Phytomolecules Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹76.72 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹9.05 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Oasis Pharma and Phytomolecules Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7.4% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.9% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Oasis Pharma and Phytomolecules are in the company report.
Premium access
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Oasis Pharma and Phytomolecules Private Limited
Oasis Pharma and Phytomolecules has 2 current directors and 12 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sanjay Dhir | Managing Director | 15 Jan 2015 | 11 Years 9 Months | Current |
| Sanjeev Kumar Also directs: Zenlabs Ethica Limited, Preet Remedies Limited, Ultra Chiron Healthcare Private Limited and 3 more | Director | 12 Dec 2014 | 11 Years 10 Months | Current |
Peer Comparison of Oasis Pharma and Phytomolecules Private Limited
Oasis Pharma and Phytomolecules Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Gujarat Liqui Pharmacaps Private Limited | ₹10.41 Cr (FY 2025) | •••• | •••• | -27.0% | •••• | Vadodara, Gujarat, India |
| Stature Life Sciences Private Limited | ₹10.4 Cr (FY 2025) | •••• | •••• | 22.0% | •••• | Chennai, Tamil Nadu, India |
| Skymax Lifescience Private Limited | ₹10.39 Cr (FY 2025) | •••• | •••• | -3.0% | •••• | Surat, Gujarat, India |
| Zieo Pharmaceuticals Private Limited | ₹10.38 Cr (FY 2025) | •••• | •••• | 37.0% | •••• | Bangalore, Karnataka, India |
| Yagmag Labs Pvt.Ltd. | ₹10.37 Cr (FY 2019) | •••• | •••• | 227.0% | •••• | Hyderabad, Telangana, India |
| Oasis Pharma and Phytomolecules Private Limited this company | ₹10.36 Cr (FY 2025) | •••• | •••• | 48.0% | •••• | Chandigarh, India |
| SVS Medicare Private Limited | ₹10.34 Cr (FY 2025) | •••• | •••• | -77.0% | •••• | Solapur, Maharashtra, India |
| Essenzaa Nutrition Private Limited | ₹10.33 Cr (FY 2024) | •••• | •••• | -5.0% | •••• | Mumbai, Maharashtra, India |
| Banson Pharmaceuticals Private Limited | ₹10.3 Cr (FY 2024) | •••• | •••• | 92.0% | •••• | Punjab, India |
| Molecular Cyclotrons Private Limited | ₹10.3 Cr (FY 2024) | •••• | •••• | 25.0% | •••• | Thrissur, Kerala, India |
| Medwin Pharmaceuticals Private Limited | ₹10.29 Cr (FY 2025) | •••• | •••• | 19.0% | •••• | Aligarh, Uttar Pradesh, India |
Peers are the five companies nearest above and the five nearest below Oasis Pharma and Phytomolecules by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Oasis Pharma and Phytomolecules Private Limited
Oasis Pharma and Phytomolecules Private Limited is audited by RAVINDER K SHARMA & CO for the financial year 2021.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| RAVINDER K SHARMA & CO | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Oasis Pharma and Phytomolecules Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Oasis Pharma and Phytomolecules Private Limited
Open charges
₹10.3 Cr
Satisfied charges
₹8.97 Cr
Breakdown by lending institutions
Latest charge details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Jun 2022 | Hdfc Bank Limited | ₹10 Cr | Open |
| 01 Jan 2014 | Deputy Director of Industries | ₹30 Lakh | Open |
| 30 Nov 2016 | Hdfc Bank Limited | ₹4.17 Cr | Satisfied |
| 29 Nov 2009 | Uco Bank | ₹4.8 Cr | Satisfied |
Total charge records: 4 View all charges
Deals & Funding of Oasis Pharma and Phytomolecules Private Limited
Oasis Pharma and Phytomolecules Private Limited has 12 deals on record (6 funding rounds, 4 secondary share transfers, 2 rights issues), with disclosed funding of ₹5.42 Cr; the latest was in April 2019.
Total deals
12
Funding rounds
6
Secondary share transfers
4
Rights issues
2
Disclosed funding
₹5.42 Cr
Deals on record (5 of 12)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Apr 2019 | Rights issue | ₹50.6 Lakh | Investors: Quixotic Healthcare Limited and Sanjeev Kumar and Satish Kumar and Harpreet Singh and Himjyoti Dhir, Preet Remedies Limited |
| Feb 2015 | Rights issue | ₹73.6 Lakh | Investors: Preet Remedies Limited |
| Dec 2014 | Secondary share transfer | Undisclosed | Buyer: Preet Remedies Limited Seller: an individual |
| Feb 2013 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: Fresh Look Aluminium and Steel Private Limited , Agp Bio Mass Products Private Limited , 2 individuals |
| Feb 2012 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: Canny Consultants Private Limited , Dhanshree Softech Private Limited , Kakani Enterprises Private Limited |
Premium access
Full deal history
All 12 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal Cases of Oasis Pharma and Phytomolecules Private Limited
Oasis Pharma and Phytomolecules Private Limited has 12 court cases on record: 3 filed by Oasis Pharma and Phytomolecules, 8 filed against it, 1 where it is another party. 2 cases are pending and 10 are disposed. Status as checked between 29 Sep 2026 and 04 Oct 2026.
Total cases
12
Filed by the company
3
Filed against the company
8
Pending
2
Disposed
10
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 10 | 8 | 2 |
| High courts | 2 | 0 | 0 |
Cases on record (5 of 12)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Thane, Maharashtra | Court case (R.C.C.) | Filed against the company by an individual | Pending |
| District court, East, Delhi | Interim or miscellaneous application | Filed against the company by an individual | Disposed |
| District court, East, Delhi | Court case (T. P. Civil) | Filed against the company by an individual | Disposed |
| High Court of Delhi | Court case (CM(M)) | Filed by the company against an individual | Disposed |
| District court, East, Delhi | Criminal case | Filed against the company by an individual | Disposed |
Premium access
Full case history
All 12 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Oasis Pharma and Phytomolecules Private Limited
Oasis Pharma and Phytomolecules Private Limited has a workforce of 11 employees as of Apr 06, 2024.
Employee count
11
Active EPFO establishments
2
Employee growth
-47.62%
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Oasis Pharma and Phytomolecules Private Limited
Oasis Pharma and Phytomolecules Private Limited has 14 board changes on record since 2013: 2 appointments and 12 cessations. The latest: Satish Kumar ceased to be Director on 30 Jun 2020.
AGM
Oasis Pharma And Phytomolecules Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Oasis Pharma And Phytomolecules Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chandigarh.
Charges
A charge with Hdfc Bank Limited of Rs. 10.00 Cr registered on 30 Jun 2022 with Charge ID 100591694 was modified on 23 Jan 2024.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 10.00 Cr with Charge ID 100591694 was registered on 30 Jun 2022.
Charges
A charge registered on 30 Nov 2016 via Charge ID 100064233 with Hdfc Bank Limited was fully satisfied on 05 Aug 2021.
Ceased
Satish Kumar ceased to be Director.
Ceased
Swapan Chakraborty ceased to be Director.
Ceased
Rajiv Sharma ceased to be Additional Director.
Ceased
Kamlesh Kumar Mishra ceased to be Additional Director.
Charges
A charge with Hdfc Bank Limited of Rs. 4.17 Cr registered on 30 Nov 2016 with Charge ID 100064233 was modified on 28 Mar 2017.
Charges
A charge registered on 29 Nov 2009 via Charge ID 10188476 with Uco Bank was fully satisfied on 13 Feb 2017.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 4.17 Cr with Charge ID 100064233 was registered on 30 Nov 2016.
14 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Oasis Pharma and Phytomolecules Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Oasis Pharma and Phytomolecules Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Oasis Pharma and Phytomolecules Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Oasis Pharma and Phytomolecules Private Limited
Oasis Pharma and Phytomolecules has 2 GST registrations: 1 active and 1 cancelled or inactive.
Total GSTINs
2
Active
1
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 02AAACO9325R1Z3 | Himachal Pradesh | Active | 01 Jul 2017 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Oasis Pharma and Phytomolecules Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Oasis Pharma and Phytomolecules Private Limited
Oasis Pharma and Phytomolecules is an active private limited company based in Chandigarh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 08 May 2007 (19+ years old) and is registered under CIN U24100CH2007PTC045485.
Oasis Pharma and Phytomolecules reported revenue of ₹10.36 Cr for FY 2025 (up 48% YoY).
Oasis Pharma and Phytomolecules has 2 current directors:
- Sanjay Dhir - Managing Director
- Sanjeev Kumar - Director
Oasis Pharma and Phytomolecules reported a net profit of ₹9.05 Lakh (net margin 0.9%) and EBITDA of ₹76.72 Lakh (EBITDA margin 7.4%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Oasis Pharma and Phytomolecules is 440% over five years. In the latest year (FY 2025) revenue rose 48%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Oasis Pharma and Phytomolecules is 02AAACO9325R1Z3, registered in Himachal Pradesh. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Oasis Pharma and Phytomolecules is U24100CH2007PTC045485. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Oasis Pharma and Phytomolecules has 12 court cases on record: 3 filed by the company and 8 filed against it. 2 are pending. Most are in the district courts.
Oasis Pharma and Phytomolecules was incorporated on 08 May 2007, making it 19+ years old. It is registered with the Registrar of Companies, Chandigarh.
Oasis Pharma and Phytomolecules has 12 deals on record (6 funding rounds, 4 secondary share transfers, 2 rights issues), with disclosed funding of ₹5.42 Cr; the latest was in April 2019.
The peers of Oasis Pharma and Phytomolecules by revenue are Gujarat Liqui Pharmacaps Private Limited, Stature Life Sciences Private Limited, Skymax Lifescience Private Limited, Zieo Pharmaceuticals Private Limited, Yagmag Labs Pvt.Ltd. and 5 more, all in the Pharma industry (Formulations).